Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only

Home/MS/Gulfport

Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Gulfport, MS

Studies commonly pay $75 to $4,500 per completed study

36 clinical trials are currently recruiting participants within 30 miles of Gulfport. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

36studies recruiting

3+research centers nearby

6condition categories

Live from the NIH registry

Studies recruiting near Gulfport right now

Top 25 of 36 recruiting studies, sorted by proximity — each links to its official registry page

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

Acute Gouty Arthritis, Gout Flare Phase 2 Interventional 380 participants sought

DelRicht Research Gulfport — Gulfport, Mississippi (4.4 mi) · Sponsor: Atom Therapeutics Co., Ltd

See eligibility & contact on ClinicalTrials.gov (NCT07145229)

Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds

Open Wound N/A Interventional 132 participants sought

MedCentris of D'iberville — D'Iberville, Mississippi (10.7 mi) · Sponsor: NuScience Medical Biologics, LLC

See eligibility & contact on ClinicalTrials.gov (NCT06918561)

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Stage I Breast Cancer Phase 3 Interventional 1,670 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: NRG Oncology

See eligibility & contact on ClinicalTrials.gov (NCT04852887)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

Advanced Malignant Solid Neoplasm, Anatomic Stage III Breast Cancer AJCC v8 Phase 2 Interventional 2,900 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: National Cancer Institute (NCI)

See eligibility & contact on ClinicalTrials.gov (NCT05564377)

A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine

Acute Migraine Phase 3 Interventional 1,000 participants sought

DelRicht Research — Gulfport, Mississippi (4.4 mi) · Sponsor: Kallyope Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07674654)

Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial

Metastatic Clear Cell Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma Phase 3 Interventional 364 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT04510597)

A Study of Orforglipron (LY3502970) in Adolescent Participants With Obesity, or Overweight With Related Comorbidities

Obesity, Overweight Phase 3 Interventional 150 participants sought

MedPharmics, LLC — Gulfport, Mississippi (4.4 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06672939)

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Obesity, Overweight Phase 3 Interventional 125 participants sought

Dynamed Clinical Research, LP d/b/a DM Clinical Research — Gulfport, Mississippi (4.4 mi) · Sponsor: Eli Lilly and Company

See eligibility & contact on ClinicalTrials.gov (NCT06672549)

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

Migraine Phase 3 Interventional 1,800 participants sought

DelRicht Research — Gulfport, Mississippi (4.4 mi) · Sponsor: Kallyope Inc.

See eligibility & contact on ClinicalTrials.gov (NCT07645924)

S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive N/A Interventional 739 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: SWOG Cancer Research Network

See eligibility & contact on ClinicalTrials.gov (NCT03723928)

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

Obesity, Heart Failure Phase 3 Interventional 5,610 participants sought

Hawthorne Health — Diamondhead, Mississippi (17.6 mi) · Sponsor: Novo Nordisk A/S

See eligibility & contact on ClinicalTrials.gov (NCT07567001)

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Obesity, Overweight Phase 3 Interventional 3,600 participants sought

ACCOMPLISH-1 Research Site — Gulfport, Mississippi (4.4 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07654361)

Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial

Plasma Cell Myeloma, RISS Stage I Plasma Cell Myeloma Phase 3 Interventional 1,450 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT04566328)

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Diabetes Mellitus, Type 2, Hypertension Phase 3 Interventional 11,800 participants sought

Memorial Hospital Gulfport — Gulfport, Mississippi (4.4 mi) · Sponsor: Boehringer Ingelheim

See eligibility & contact on ClinicalTrials.gov (NCT07064473)

MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study

Lumbar Spinal Stenosis N/A Observational 8,000 participants sought

Singing River Gulfport — Gulfport, Mississippi (4.4 mi) · Sponsor: Stryker Instruments

See eligibility & contact on ClinicalTrials.gov (NCT03072927)

A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease

Graves' Disease Phase 2 Interventional 240 participants sought

Site Number - 1068 — Gulfport, Mississippi (4.4 mi) · Sponsor: Immunovant Sciences GmbH

See eligibility & contact on ClinicalTrials.gov (NCT06727604)

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Obesity, Overweight Phase 3 Interventional 1,100 participants sought

ACCOMPLISH-2 Research Site — Gulfport, Mississippi (4.4 mi) · Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT07654374)

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Hypertension N/A Interventional 261 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: SoniVie Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06559891)

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Obesity, Overweight Phase 3 Interventional 1,560 participants sought

AURORA-2 Clinical Site — Gulfport, Mississippi (4.4 mi) · Sponsor: Ascletis Pharma (China) Co., Limited

See eligibility & contact on ClinicalTrials.gov (NCT07743450)

Tissue Repair Gel in Venous Leg Ulcers (US)

Venous Leg Ulcer, Venous Ulcer Phase 3 Interventional 312 participants sought

Clincial Research Site 07 — D'Iberville, Mississippi (10.7 mi) · Sponsor: TR Therapeutics

See eligibility & contact on ClinicalTrials.gov (NCT06707090)

A Study to Investigate the Immunogenicity and Safety of mRNA COVID-19 Variant-containing Vaccine Formulations

SARS-CoV-2 Phase 4 Interventional 1,144 participants sought

Velocity Clinical Research — Gulfport, Mississippi (4.4 mi) · Sponsor: ModernaTX, Inc.

See eligibility & contact on ClinicalTrials.gov (NCT06585241)

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

Respiratory Distress Syndrome, Acute Phase 2 Interventional 52 participants sought

Ocean Springs Hospital — Ocean Springs, Mississippi (14.5 mi) · Sponsor: GEn1E Lifesciences

See eligibility & contact on ClinicalTrials.gov (NCT05795465)

Mobile Health for Adherence in Breast Cancer Patients

Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma N/A Interventional 410 participants sought

Gulfport Memorial Hospital — Gulfport, Mississippi (4.4 mi) · Sponsor: ECOG-ACRIN Cancer Research Group

See eligibility & contact on ClinicalTrials.gov (NCT06112613)

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Obesity or Overweight Phase 3 Interventional 2,000 participants sought

DelRicht Research at Gulfport Memorial — Gulfport, Mississippi (4.4 mi) · Sponsor: Hoffmann-La Roche

See eligibility & contact on ClinicalTrials.gov (NCT07351045)

A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR)

Cataract Phase 3 Interventional 528 participants sought

Tekwani Vision Center — Bay Saint Louis, Mississippi (17.5 mi) · Sponsor: Melt Pharmaceuticals

See eligibility & contact on ClinicalTrials.gov (NCT06383273)

Actively enrolling

Studies you may be able to join near Gulfport

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Google-rated

Top-rated research centers in Gulfport

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

DelRicht Research of Clinical Trials Gulfport

★ 4.9

8970 Lorraine Rd, Gulfport, MS 39503

(228) 588-8268

Website

"Bedside manner and care is excellent❤️‍🩹"

— Angella Quince, 4★

Velocity Clinical Research

★ 4.1

15444 Dedeaux Rd B, Gulfport, MS 39503

(228) 206-1283

Website

"Have done 3 trials there all were smooth and staff keep up the great work ty."

— four reals, 5★

DelRicht Research of Gulfport Clinical Trials

★ 5.0

4333 15th St A, Gulfport, MS 39501

(228) 588-8268

Website

"Very good experience and wonderful staff"

— patricia fleming, 5★

Clinical trials in Gulfport: what's recruiting

The Gulfport area currently has 36 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Gulfport, the most active research areas are:

Diabetes & Metabolism8 studies
Cancer & Oncology6 studies
Heart & Vascular3 studies
Immune & Skin1 studies
Liver & Kidney1 studies

Every listing shows the study phase, the recruiting site and its distance from Gulfport, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Gulfport

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Gulfport participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Gulfport pay?

Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.

Are clinical trials in Gulfport safe?

Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.

How do I join a study in Gulfport, MS?

Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.

How often do new paid studies open in Gulfport?

Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Gulfport.

Can I be in more than one clinical trial at a time?

Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Gulfport typically complete one or two studies per year.

Paid clinical trials near Gulfport

Other metros within reach

New Orleans, LA556 Mobile, AL173 Metairie, LA527 Pensacola, FL135 Baton Rouge, LA224 Jackson, MS227 Lafayette, LA58 Tuscaloosa, AL25

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Gulfport Bladder Issues Due To Spinal Cord Injury in Gulfport All conditions

More of MS

Jackson227

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

Get free trial alerts